My Steps for Healthy Living – Registration

How My Steps for Healthy Living works

Remember, before beginning any physical activity, consult with your doctor to make sure the activity is right for you.

  1. After you enroll, you'll receive a welcome kit with an outline of the program, a pedometer, a log sheet for recording your steps, and a postage-paid 'report card.'
  2. At the end of each month, record your steps on the report card and mail it back, or record your steps online. Your goal is to increase your number of steps by 10% each month. If you aren't able to increase your steps by 10% in a certain month, don't worry – and don't give up! Remember: You don't have to walk fast or for long periods of time to benefit!
  3. After you submit your report card, you will receive a motivational reward as well as a new report card for the next month. It's our way of congratulating you on a job well done. We want to help you keep your momentum going. So keep rising to the challenge by walking a little more each day.
  • Fields marked with an asterisk (*) are required.
Verification Code

Prior to submitting your information, please review our Privacy Policy.

Important Safety Information

Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.

Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.

In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).

Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Please see full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.